BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 12837246)

  • 1. Multiple tumor suppressor pathways negatively regulate telomerase.
    Lin SY; Elledge SJ
    Cell; 2003 Jun; 113(7):881-9. PubMed ID: 12837246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements.
    Casillas MA; Brotherton SL; Andrews LG; Ruppert JM; Tollefsbol TO
    Gene; 2003 Oct; 316():57-65. PubMed ID: 14563552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression.
    Horikawa I; Cable PL; Mazur SJ; Appella E; Afshari CA; Barrett JC
    Mol Biol Cell; 2002 Aug; 13(8):2585-97. PubMed ID: 12181331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of transformed IMR90 cell model to identify the potential extra-telomeric effects of hTERT in cell migration and DNA damage response.
    Cao X; Kong CM; Mathi KM; Lim YP; Cacheux-Rataboul V; Wang X
    BMC Biochem; 2014 Aug; 15():17. PubMed ID: 25098897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1.
    Cerni C; Skrzypek B; Popov N; Sasgary S; Schmidt G; Larsson LG; Lüscher B; Henriksson M
    Oncogene; 2002 Jan; 21(3):447-59. PubMed ID: 11821957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres.
    Guilleret I; Benhattar J
    Exp Cell Res; 2003 Oct; 289(2):326-34. PubMed ID: 14499633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras.
    MacKenzie KL; Franco S; Naiyer AJ; May C; Sadelain M; Rafii S; Moore MA
    Oncogene; 2002 Jun; 21(27):4200-11. PubMed ID: 12082607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
    Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
    Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
    Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M
    Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.
    Dimri GP; Martinez JL; Jacobs JJ; Keblusek P; Itahana K; Van Lohuizen M; Campisi J; Wazer DE; Band V
    Cancer Res; 2002 Aug; 62(16):4736-45. PubMed ID: 12183433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F-1 represses transcription of the human telomerase reverse transcriptase gene.
    Crowe DL; Nguyen DC; Tsang KJ; Kyo S
    Nucleic Acids Res; 2001 Jul; 29(13):2789-94. PubMed ID: 11433024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
    Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
    Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-1 bZIP factor impedes the menin tumor suppressor and upregulates JunD-mediated transcription of the hTERT gene.
    Borowiak M; Kuhlmann AS; Girard S; Gazzolo L; Mesnard JM; Jalinot P; Dodon MD
    Carcinogenesis; 2013 Nov; 34(11):2664-72. PubMed ID: 23784080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins.
    Ramirez RD; Sheridan S; Girard L; Sato M; Kim Y; Pollack J; Peyton M; Zou Y; Kurie JM; Dimaio JM; Milchgrub S; Smith AL; Souza RF; Gilbey L; Zhang X; Gandia K; Vaughan MB; Wright WE; Gazdar AF; Shay JW; Minna JD
    Cancer Res; 2004 Dec; 64(24):9027-34. PubMed ID: 15604268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.
    Sun B; Chen M; Hawks CL; Hornsby PJ
    Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms.
    Horikawa I; Barrett JC
    Carcinogenesis; 2003 Jul; 24(7):1167-76. PubMed ID: 12807729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity.
    Yi X; White DM; Aisner DL; Baur JA; Wright WE; Shay JW
    Neoplasia; 2000; 2(5):433-40. PubMed ID: 11191110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1.
    Günes C; Lichtsteiner S; Vasserot AP; Englert C
    Cancer Res; 2000 Apr; 60(8):2116-21. PubMed ID: 10786671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer.
    Lee SH; Kim JW; Oh SH; Kim YJ; Rho SB; Park K; Park KL; Lee JH
    FEBS Lett; 2005 Feb; 579(5):1027-33. PubMed ID: 15710386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oncogene expression on telomerase activation and telomere length in human endothelial, fibroblast and prostate epithelial cells.
    Burger AM; Fiebig HH; Kuettel MR; Lautenberger JA; Kung HF; Rhim JS
    Int J Oncol; 1998 Nov; 13(5):1043-8. PubMed ID: 9772298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.